NHMRC Public Consultations

Skip Navigation and go to Content
Visit NHMRC website

PSA Testing for Prostate Cancer in Asymptomatic Men: Information for Health Practitioners submission

ID: 
16
Personal Details
First Name: 
Dr Michael
Last Name: 
Homewood
Specific Questions
6. Does PSA testing in asymptomatic men reduce their overall risk of dying?: 

Does PSA Testing in asymptomatic men increase their risk of dying (from interventions) ie.for every 1000 tested how many men die from interventions or their complications

General Comments
18. Considering the Information Document is for Health Practitioners, do you have any other comments?: 

Part 1 to Submission:

This is to give you feedback on proposed guidelines

  1. It would be very important to have an information page to hand to patients regarding the issues around prostate cancer screening.
  2. Is there any information on screening outcomes for patients with a family history of prostate cancer . How should our advice vary for them.
  3. Under the heading   "Expected Harms of PSA Testing" Can you answer the question

For every  1000 men tested , how may men die of the interventions?

I think these guidelines are  a great thing to develop. A one page laminated summary would be a great tool to have.

 

Part 2 to submission

  1. Is there any infomation on screening outcomes for patients with a family history of prostate cancer
  2. It would be very important to have an information page to hand patients regarding the issues around prostate cancer screening. Patients have trouble understanding no testings decisions when they develop prostate cancer. 

Page reviewed: 4 March, 2014